Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7456161
APP PUB NO 20040082522A1
SERIAL NO

10454061

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for treating or preventing chronic obstructive pulmonary disease (COPD) by using as active agent a non-glucorticoid steroid, analogue thereof, such as dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S), or their salts, in an amount effective for preventing or treating COPD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EPIGENESIS PHARMACEUTICALS LLC7 CLARKE DRIVE CRANBURY NJ 08512

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nyce, Jonathan W Titusville, NJ 33 698

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation